Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | KDM1A | O60341 | 2/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4622004 | 1.00 | CA1 (0.50) | CA1CA2CA12CA7CA9 | |
| SCHEMBL4622000 | 1.00 | CA1 (0.50) | CA1CA2CA12CA7CA9 | |
| SCHEMBL31255971 | 0.98 | CA12 (0.48) | CA1CA2CA12CA7CA9 | |
| SCHEMBL11686766 | 0.86 | CA1 (0.55) | CA1CA2CA12CA7CA9 | |
| SCHEMBL4158886 | 0.83 | PTAFR (0.37) | SLC6A2SLC6A3PTAFR | |
| SCHEMBL9420903 | 0.82 | CYP2A6 (0.53) | CA1CA12CA7CA9CA14 | |
| SCHEMBL20215838 | 0.80 | CA12 (0.48) | CA1CA2CA12CA7CA9 | |
| SCHEMBL11183231 | 0.77 | ALDH1A1 (0.50) | MEN1ALDH1A1KMT2APTAFR | |
| SCHEMBL11162641 | 0.77 | HTR2C (0.50) | CA1CA2CA7CA9NPC1 | |
| SCHEMBL29424037 | 0.77 | GABRA1 (0.48) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1683791-B1 | Process for the epoxidation of olefins with hydrogen peroxide by ruthenium complex catalysed reaction | SALTIGO GMBH (DE) | 2008-04-02 | — | — | EP | disclosed |
| CN-1817871-A | Process for the ruthenium-catalyzed epoxidation of olefins with the aid of hydrogen peroxide | LANXESS DEUTSCHLAND GMBH (DE) | 2006-08-16 | — | — | CN | disclosed |
| EP-1683791-A1 | Process for the epoxidation of olefins with hydrogen peroxide by ruthenium complex catalysed reaction | Lanxess Deutschland GmbH (DE) | 2006-07-26 | — | — | EP | disclosed |
| US-20060161011-A1 | Process for the ruthenium-catalysed epoxidation of olefins by means of hydrogen peroxide | LANXESS DEUTSCHLAND GMBH (DE) | 2006-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060161011-A1 | Process for the ruthenium-catalysed epoxidation of olefins by means of hydrogen peroxide | PPOX, HAO2, GPX4 | CA1 2659/4885CA2 3036/4885CA12 2804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.